1. Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions
   Joanna Budna et al, 2018, Journal of Immunology Research CrossRef
2. Receptor activator of nuclear factor kappa‐B ligand (RANKL)/RANK signaling promotes cancer‐related inflammation through M2 macrophages
   Taku Fujimura et al, 2016, Experimental Dermatology CrossRef
3. Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema
   Chia-Yu Yang et al, 2021, Scientific Reports CrossRef
4. IRF4 is Correlated with the Conversion to a Th17-Like Phenotype in Regulatory T Cells from the Malignant Pleural Effusion
   Wenqing Yu et al, 2021, International Journal of General Medicine CrossRef
5. Migrated T lymphocytes into malignant pleural effusions: an indicator of good prognosis in lung adenocarcinoma patients
   Juan C. Nieto et al, 2019, Scientific Reports CrossRef
6. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
   Erin A. Marshall et al, 2016, Molecular Cancer CrossRef
7. New insights on pleural fluid formation: potential translational targets
   Malamati Vreka et al, 2016, Current Pulmonology Reports CrossRef
8. Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy
   Laura A. Huppert et al, 2022, Cellular & Molecular Immunology CrossRef
9. Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating Helios levels
   Wen-Qing Yu et al, 2019, Chinese Medical Journal CrossRef
10. Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer
    Chen Liu et al, 2017, International Journal of Oncology CrossRef
11. Regulatory T cells in multiple sclerosis and myasthenia gravis
    K. M. Danikowski et al, 2017, Journal of Neuroinflammation CrossRef
12. Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion
    Yiran Niu et al, 2022, Cellular and Molecular Life Sciences CrossRef
13. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation
    Xing Ke et al, 2016, Cancer Immunology, Immunotherapy CrossRef
14. Malignant Nonhematological Effusion Characterization by Flow Cytometry
    Ben Davidson, 2016, Acta Cytologica CrossRef
15. Helper T cells in malignant pleural effusion
    Feng-Shuang Yi et al, 2021, Cancer Letters CrossRef
16. Regulation of CD4+CD25+FOXP3+ cells in Pediatric Acute Lymphoblastic Leukemia (ALL): Implication of cytokines and miRNAs
    Eman A. El-maadawy et al, 2020, Molecular Immunology CrossRef
17. Retinoic acid induces antimicrobial peptides and cytokines leading to Mycobacterium tuberculosis elimination in airway epithelial cells
    Yolanda M. Jacobo-Delgado et al, 2021, Peptides CrossRef
18. IL-17A-producing T cells are associated with the progression of lung adenocarcinoma
    Zhang Bao et al, 2016, Oncology Reports CrossRef
19. Efferocytosis fuels malignant pleural effusion through TIMP1
    Lilan Zhao et al, 2021, Science Advances CrossRef
20. Regulatory T cells in malignant pleural effusions subsequent to lung carcinoma and their impact on the course of the disease
    J. Budna et al, 2017, Immunobiology CrossRef
21. Long‐term prognostic significance of interleukin‐17‐producing T cells in patients with non‐small cell lung cancer
    Li Song et al, 2019, Cancer Science CrossRef
22. Immunotherapy for Esophageal Cancer
    Tian Wang et al, 2018, Esophageal Cancer and Beyond CrossRef